Viewing Study NCT00614250


Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2026-02-24 @ 12:25 AM
Study NCT ID: NCT00614250
Status: COMPLETED
Last Update Posted: 2009-07-20
First Post: 2008-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea
Sponsor: Sanofi
Organization:

Study Overview

Official Title: A Double-blind, Randomized, Placebo-controlled, Study of the Safety and Activity of Four Escalating Single Doses of AVE0657 in Patients Suffering From Obstructive Sleep Apnea Hypopnea Syndrome
Status: COMPLETED
Status Verified Date: 2009-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective of this study is to assess the activity of 4 escalating doses of AVE0657 in comparison to placebo in patients with Obstructive Sleep Apnea Hypopnea Syndrome.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
EudraCT 2007-002174-58 None None View